YWHAZ
14-3-3 protein zeta/delta
Also known as: 14-3-3-zeta, 1433Z_HUMAN, KCIP-1, YWHAD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P63104
- Gene
- YWHAZ
- Ensembl
- ENSG00000164924
- Chromosome
- 8
- Canonical length
- 245 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transporters
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene product belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 99% identical to the mouse, rat and sheep orthologs. The encoded protein interacts with IRS1 protein, suggesting a role in regulating insulin sensitivity. Several transcript variants that differ in the 5' UTR but that encode the same protein have been identified for this gene. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
245 residues, UniProt reviewed canonical sequence.
>P63104|YWHAZ
1 MDKNELVQKA KLAEQAERYD DMAACMKSVT EQGAELSNEE RNLLSVAYKN VVGARRSSWR
61 VVSSIEQKTE GAEKKQQMAR EYREKIETEL RDICNDVLSL LEKFLIPNAS QAESKVFYLK
121 MKGDYYRYLA EVAAGDDKKG IVDQSQQAYQ EAFEISKKEM QPTHPIRLGL ALNFSVFYYE
181 ILNSPEKACS LAKTAFDEAI AELDTLSEES YKDSTLIMQL LRDNLTLWTS DTQGDEAEAG
241 EGGENLocalizationUniProt · AlphaFold · HPA
Whether an antibody against YWHAZ can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 839 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 839 nTPM
- tonsil: 530 nTPM
- cerebral cortex: 506 nTPM
- bone marrow: 498 nTPM
- urinary bladder: 468 nTPM
- colon: 445 nTPM
Single-cell type
- late spermatids: 3,159 nCPM
- esophageal apical cells: 2,310 nCPM
- platelets: 1,780 nCPM
- neutrophils: 1,644 nCPM
- suprabasal keratinocytes: 1,396 nCPM
- early spermatids: 1,376 nCPM
Immune cell
- basophil: 1,346 nTPM
- total PBMC: 1,088 nTPM
- non-classical monocyte: 731 nTPM
- eosinophil: 708 nTPM
- T-reg: 666 nTPM
- neutrophil: 620 nTPM
Brain region
- cerebral cortex: 848 nTPM
- hippocampal formation: 780 nTPM
- basal ganglia: 759 nTPM
- thalamus: 676 nTPM
- hypothalamus: 665 nTPM
- amygdala: 587 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about YWHAZ.
Disease | AllUniProt
Conditions YWHAZ is implicated in, by any mechanism.
- Popov-Chang syndrome (POPCHAS) MIM:618428
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 66 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Popov-Chang syndrome
- Cardiofaciocutaneous spectrum disorder
Disease | ImmuneIEDB
Conditions an epitope on YWHAZ was assayed in.
- type 1 diabetes mellitus T cell
ReferencesPubMed · IEDB
Publications for YWHAZ from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer.
2019 · J Cancer Res Clin Oncol · RCR 0.7 · 14 citations - A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.
2014 · Tumour Biol · RCR 0.6 · 18 citations - 14-3-3ζ-A Novel Immunogen Promotes Inflammatory Cytokine Production.
2019 · Front Immunol · RCR 0.5 · 11 citations - Identification of 14‑3‑3ζ as a potential biomarker in gastric cancer by proteomics‑based analysis.
2017 · Mol Med Rep · RCR 0.3 · 8 citations - Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis.
2021 · Front Oncol · RCR 0.2 · 2 citations
Reference: T cellIEDB
1 publication
- CD4+ T Cells From Individuals With Type 1 Diabetes Respond to a Novel Class of Deamidated Peptides Formed in Pancreatic Islets.
2024 · Diabetes · RCR 0.6 · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.36
- gnomAD pLI
- 0.94
- gnomAD missense Z
- 3.1
- DepMap mean gene effect
- -0.68
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 18% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- cellular response to glucose starvation
- ERK1 and ERK2 cascade
- establishment of Golgi localization
- Golgi reassembly
- intracellular protein localization
- lung development
- negative regulation of apoptotic process
- negative regulation of innate immune response
- negative regulation of protein localization to nucleus
- negative regulation of TORC1 signaling
- negative regulation of transcription by RNA polymerase II
- protein phosphorylation
- protein targeting
- regulation of ERK1 and ERK2 cascade
- regulation of protein stability
- regulation of synapse maturation
- respiratory system process
- signal transduction
- synaptic target recognition
- tube formation
Molecular functions
- cadherin binding
- DNA-binding transcription factor binding
- identical protein binding
- phosphoserine residue binding
- protein domain specific binding
- protein kinase binding
- protein phosphatase binding
- protein sequestering activity
- RNA binding
- transmembrane transporter binding
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of YWHAZ in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads YWHAZ as an antibody target. Whether an autoantibody or antibody against YWHAZ could matter depends on whether native YWHAZ is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
YWHAZ is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label YWHAZ as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...